340B Guidance Documents Removed from HHS Public Database

It is not known when the majority of the 340B guidance documents disappeared from the HHS Guidance Portal, who took them down, or why.

Nearly all 340B-related program guidance documents have been taken down from an online database that the Trump administration launched last summer to underscore its position that federal government guidance documents are non-binding.

The U.S. Health Resources and Services Administration’s (HRSA)

Read More »

340B Report Publisher/CEO: It Will Take Time for Contract Pharmacy Battle to Play Out

Recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting, 340B Report Publisher and CEO Ted Slafsky’s take in his latest column for the Omnicell blog

The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report

Read More »

AHA Asks CMS to Withdraw Trump’s Most Favored Nation Drug Pricing Rule

During an October 2018 event at HHS, former President Trump promised to end "global freeloading" that caused Americans to pay higher drug prices. | Source: C-SPAN

The American Hospital Association (AHA) asked the Biden administration this week to immediately withdraw the Trump administration’s “most favored nation” (MFN) drug pricing interim final rule, in part, because of the damage it will do to 340B hospitals and “critical

Read More »

Drug Company Eton Posts 340B Limited Distribution Notice

Illinois-based Eton Pharmaceuticals is making its Alkindi Sprinkle hydrocortisone product available through a sole specialty distributor “to ensure that patients…receive appropriate drug and clinical counseling and to support therapeutic adherence,” the company informed 340B covered entities in a Jan. 12

Read More »

New Walgreens Leader Will Be Fortune 500’s Sole Black Female CEO

Walgreens Boots Alliance has chosen Roz Brewer to be its new CEO effective March 15. She will be the sole Black woman running a Fortune 500 company.

Walgreens Boots Alliance (WBA) this week appointed veteran business chief executive Rosalind (Roz) Brewer as WBA’s chief executive officer effective March 15. The appointment will make Brewer the sole Black female CEO of a Fortune 500 company.

Brewer most recently

Read More »

340B COVID-19 Flexibilities Expected to Run Through the End of 2021

The announcement Friday that the COVID-19 national public health emergency probably will last all year probably means COVID-related 340B program flexibilities will last all year, too.

The acting head of the U.S. Health and Human Services Department (HHS) told state governors on Friday that the national COVID-19 public health emergency (PHE) is expected to last through the end of the year. That likely means 340B program

Read More »

Conservative News Sites Cast Shade on Biden’s Freeze on 340B Insulin Rule

Health center advocates are responding to social media posts that suggest that, by freezing a Trump administration rule regarding health centers' 340B pricing on insulin, the Biden administration raised insulin's price.

Health center advocates are trying to stamp out fast-spreading claims on social media that the Biden administration, in freezing a Trump administration rule, raised the price of insulin.

Facebook and Twitter have been filled with posts and counter-posts about the

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report